Insmed Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$149.86

-1.17 (-0.77%)

As of Feb 8, 3:10 PM ET ·

Income Statement

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Revenue	472.85M	379.83M	46.35B	44.36B	43.93B
Net Income	-1,187,997,201	-858,862,142	1.20B	1.08B	1.36B
EPS	—	—	—	—	—
Profit Margin	-251.2%	-238.7%	2.6%	2.4%	3.1%
Rev Growth	+24.5%	+24.5%	-8.3%	+19.4%	+5.8%

Balance Sheet

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Total Debt	13.09B	13.09B	7.96B	8.61B	10.21B
Total Equity	2.89B	2.89B	27.56B	24.15B	26.36B
D/E Ratio	4.53	4.53	0.29	0.36	0.39

Cash Flow

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
EBITDA	-1,135,531,928	-866,539,747	2.39B	2.00B	1.93B
Free Cash Flow	—	—	977.06M	843.11M	852.61M